FDA Drug recall D-0285-2024
Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Oh…
- FDA Drug
- Class II
- terminated
- Published 2024-02-07
On 2024-02-07 the FDA classified a Class II recall of Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Oh… by Amerisource Health Services, citing failed Impurities/Degradation Specification.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0285-2024 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2024-01-11 |
| Published | 2024-02-07 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Amerisource Health Services |
| Distribution | US |
Product
Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-575-21; NDC Unit Dose: 60687-575-11
Reason
Failed Impurities/Degradation Specification.
Identifiers
| ndc | 60687-586-11 |
|---|---|
| ndc | 60687-586-01 |
| ndc | 60687-575-11 |
| ndc | 60687-575-21 |
| code_info | Lot #: 1008111, Exp. Date 01/31/2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0285-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.